# Reyvow

NDC: 0002-4312
Generic name: lasmiditan
Labeler / Manufacturer: Eli Lilly and Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20191011

FDA application: NDA211280

## Active ingredients

- LASMIDITAN: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0002-4312"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0002-4312
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aea3358c-ff41-4490-9e6d-c7bf7b3de13f